Kiniksa Pharmaceuticals Ltd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Kiniksa Pharmaceuticals Ltd
CIK #0001730430
EDGAR Form CIK 2011 - 2026
10-K [0001730430]
10-Q [0001730430]
3 [0001730430]
4 [0001730430]
5 [0001730430]
8-K [0001730430]
D [0001730430]
SC 13D [0001730430]
SC 13G [0001730430]
Form 13D/13G Filer Form 13D/13G Subject Filed
FMR LLC Kiniksa Pharmaceuticals International PLC [2026-03-06]
Tang Capital Management LLC Kiniksa Pharmaceuticals International PLC [2025-04-04]
BlackRock Inc Kiniksa Pharmaceuticals International PLC [2024-11-08]
BlackRock Inc Kiniksa Pharmaceuticals International PLC [2024-10-21]
Rubric Capital Management LP Kiniksa Pharmaceuticals Ltd [2024-02-12]
BlackRock Inc Kiniksa Pharmaceuticals Ltd [2024-01-25]
Fairmount Funds Management LLC Kiniksa Pharmaceuticals Ltd [2023-08-10]
Pictet Asset Management Sa Kiniksa Pharmaceuticals Ltd [2023-02-03]
BlackRock Inc Kiniksa Pharmaceuticals Ltd [2022-09-08]
Pictet Asset Management Sa Kiniksa Pharmaceuticals Ltd [2022-02-10]
BlackRock Inc Kiniksa Pharmaceuticals Ltd [2021-11-24]
BlackRock Inc Kiniksa Pharmaceuticals Ltd [2021-11-10]
Consonance Capital Management LP Kiniksa Pharmaceuticals Ltd [2020-06-16]
Ameriprise Financial Inc Kiniksa Pharmaceuticals Ltd [2020-02-14]
Hillhouse Capital Advisors Ltd Kiniksa Pharmaceuticals Ltd [2019-02-14]
ArrowMark Colorado Holdings LLC Kiniksa Pharmaceuticals Ltd [2019-02-14]
Vanguard Group Inc Kiniksa Pharmaceuticals Ltd [2019-02-11]
Desnick Robert Kiniksa Pharmaceuticals Ltd [2018-07-19]
Cormorant Asset Management LP Kiniksa Pharmaceuticals Ltd [2018-06-04]
Baker Bros Advisors LP Kiniksa Pharmaceuticals Ltd [2018-05-31]
Flynn James E Kiniksa Pharmaceuticals Ltd [2018-05-31]
Form 3/4/5 Subject 2011 - 2026
Malkani Dhiraj H
Kiniksa Pharmaceuticals International PLC
Popovits Kimberly J
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Baker Bros Advisors LP
Quart Barry D
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-03-09 Sell 17,981 $45.58 819,574
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
2026-03-09 Option exercise 13,813 $0.00
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
2026-03-09 Option exercise 10,513 $0.00
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-03-09 Option exercise 10,360 $26.74 277,026
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-03-09 Option exercise 13,813 $18.06 249,463
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-03-09 Sell 18,741 $46.24 866,584
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
2026-03-09 Option exercise 10,360 $0.00
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-03-09 Option exercise 10,513 $17.76 186,711
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-03-09 Option exercise 2,036 $22.89 46,604
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
2026-03-09 Option exercise 2,036 $0.00
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-03-02 Sell 12,063 $44.20 533,185
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-03-02 Option exercise 40,000 $10.36 414,400
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
2026-03-02 Option exercise 40,000 $0.00
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-03-02 Sell 22,223 $44.88 997,368
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-03-02 Sell 5,714 $45.92 262,387
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-02-12 Option exercise 2,690 $15.47 41,614
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
2026-02-12 Option exercise 2,690 $0.00
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-02-12 Sell 2,690 $45.00 121,050
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-02-10 Sell 110 $45.00 4,950
Kiniksa Pharmaceuticals International PLC KNSA
Class A Ordinary Share
2026-02-10 Option exercise 110 $15.47 1,702
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com